|
- The RestoreX Solution | RestoreX by Pathright Medical
RestoreX is the only traction therapy device to initiate a randomized, controlled clinical trial in the USA in men with chronic Peyronie’s disease The 3-month results from the study of men with PD were published in the Journal of Urology in September 2019 and the 6-month results presented at a recent Urology conference (March 2019)
- FAQs | RestoreX by Pathright Medical
RestoreX is the only device that has been clinically tested and proven using a randomized, controlled study design Similarly, the clinical studies with RestoreX have shown the above improvements in men using the device for 60 minutes daily for 12 weeks
- Clinical Results - RestoreX
Clinical Results for Penile Lengthening RestoreX® for Lengthening, Post-Prostatectomy RestoreX® for Lengthening, Chronic Disease
- RestoreX Training | RestoreX by Pathright Medical
The following training and resources will assist in using your RestoreX penile traction therapy device Prior to using RestoreX for the first time, it must be customized for your specific anatomy and condition to achieve optimal results
- Compare RestoreX - RestoreX
RestoreX is the only traction device with a patented counterbending mechanism The counterbending mechanism can be adjusted to target specific regions of the penis affected by Peyronie’s disease
- Penile Traction Therapy Device for Lengthening - RestoreX
The following training and resources will assist in using your RestoreX penile traction therapy device for lengthening Prior to using RestoreX for the first time, it must be customized for your specific anatomy to achieve optimal results
- About Us | RestoreX by Pathright Medical
Since its introduction, Restorex has been more researched than any other traction device and remains the only device developed by a Board Certified Urologist specializing in Men’s Health and Peyronie’s disease
- Easy-to-Use Peyronies Treatment - RestoreX
RestoreX was tested in a randomized, controlled clinical trial in men with chronic Peyronie’s disease at Mayo Clinic, Rochester Results were published in The Journal of Urology in September 2019
|
|
|